Functional annotation and identification of putative drug target in strain ankara

      Background: Strain Ankara has proved a great help to the mankind for eradicating life-threatening pox disease. In past two decades, it has been realized that its role was not limited to develop vaccine only but extended widely as potential therapeutics against cancer and understanding several mechanisms related to virus-host interactions. With the advent of new technologies in the field of molecular biology and immune therapeutics, this virus has taken a prime and promising place to employ as the therapeutic agent against cancer. The oncolytic potential of Strain Ankara has been documented significantly through early clinical trials. Strain Ankara has been used more broadly for human immunization than another vaccine.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect